Searchable abstracts of presentations at key conferences in endocrinology

ea0025pl2biog | Society for Endocrinology Hoffenberg International Medal Lecture | SFEBES2011

Society for Endocrinology Hoffenberg International Medal Lecture

Fuller Peter J

Peter J Fuller, Prince Henry’s Institute, Clayton, Victoria, Australia. AbstractProfessor Fuller is an NHMRC Senior Principal Research Fellow at Prince Henry's Institute of Medical Research in Melbourne where is the Associate Director and Head of the Steroid Receptor Biology Group. He is also Director of the Endocrinology Unit at the Monash Medical Centre/Southern Health and an Adjunct Professor in Medicine and ...

ea0070aep871 | Thyroid | ECE2020

Catch it if you know – A rare case of impaired TSH measurement

Hoskin Katja , Capraro Joel , Neyer Peter J , Rusch Sebastian

Introduction: Thyreotropin (TSH) is a glycoprotein containing an alpha-subunit similar to other glycoproteins (LH, FSH, ACTH, HCG) and a unique beta-subunit which reacts with the alpha-subunit in binding to the TSH-receptor. Low TSH levels are usually evidence of primary hyperthyreoidism as in Graves diseases/ toxic goiter or thyroiditis, or a result of secondary hypothyroidism in case of diseases of the pituitary gland. This case shows a rare variant causing apparently low TS...

ea0069p5 | Poster Presentations | SFENCC2020

Isolated ACTH-deficiency following immune checkpoint inhibitors: diagnostic challenges demonstrated by a clinical case

Chatzimavridou-Grigoriadou Victoria , Higham Claire E , Lorigan Paul , Dhage Shaishav S , Trainer Peter J , Adam Safwaan

Case history: A 53-year-old male with melanoma who had a previous surgical excision of his skin lesion in December 2018 was being treated with adjuvant pembrolizumab. In June 2019 his treatment changed to combination immune checkpoint inhibitor therapy (ICPi) with ipilimumab and nivolumab due to radiological recurrence.Investigations: There were no pre-ICPi endocrine investigations available. In July 2019, thyroid function tests (TFTs) showed thyroid-sti...

ea0041oc8.1 | Thyroid - Translational | ECE2016

Non-genomic effects of thyroid hormones on endothelial cell tube formation

Schmohl Kathrin A , Dohmann Maike , Wechselberger Alexandra , Nelson Peter J , Spitzweg Christine

Wound healing and tumour stroma formation are associated with angiogenesis and require interactions of various different cell types. We and others have shown that mesenchymal stem cells (MSCs) differentiate into fibroblast-/pericyte-like cells and secrete proangiogenic factors. Thyroid hormones act as proangiogenic modulators mediated by non-genomic mechanisms via cell surface receptor integrin αvβ3. The aim of this study is to evaluate the stimulatory activity of T3...

ea0038p142 | Growth and development | SFEBES2015

Human foetal adrenal gland development and effects of maternal smoking

Johnston Zoe C , Filis Panagiotis , Bellingham Michelle , O'Shaughnessy Peter J , Fowler Paul A

Introduction: The human foetal adrenal gland (HFA) is a highly active endocrine organ, producing large amounts of DHEA and DHEAS. Our understanding of HFA development is limited, however, and species differences mean that animal models are only of partial use. Maternal cigarette smoking is known to increase the post-natal risk of health complications of the foetus, and the mechanisms involved may include effects on the HFA.Aim: To examine normal HFA deve...

ea0034p308 | Pituitary | SFEBES2014

Inhibition of lipolysis improves peripheral and hepatic insulin sensitivity and restores first phase insulin response in patients with acromegaly

McGlynn Stephen J , Bluck Les , Salgin Burak , Trainer Peter J , Williams Steve , Higham Claire E

Acromegaly causes impaired insulin sensitivity and reduced fat mass. Using acipimox to block lipolysis, the impact of free fatty acids (FFA) on insulin sensitivity in active acromegaly was investigated. 1H MRS was used to quantify triglyceride (TG) content of liver and muscle.Methods: 6 patients with active acromegaly (AA) (5M, age 59 (34–70), IGF-I (ng/ml) (median (range)) (452 (342–1002)) were studied on 2 visits; (i) baseline (BL)...

ea0013p277 | Steroids | SFEBES2007

The effect of septic serum on adenylyl cyclase and adrenocortical responsiveness in vitro and in vivo

Chung Teng-Teng , King Peter J , Hinds Charles , Clark Adrian J

Attenuation of the adrenocortical response to ACTH in septic shock is a well recognised phenomenon, although the underlying mechanisms remain poorly understood. The evidence points towards factors in septic serum that dampen the adrenocortical responsiveness. The aim of this work is to investigate the cellular function of adrenocortical cells in septic shock and to determine the components within serum that could influence their function. Septic rat serum was collected from ma...

ea0012p56 | Endocrine tumours and neoplasia | SFE2006

Dopamine-secreting paraganglioneuroma – maintain high index of suspicion

Mallina Ravi K , Simon Godwin , Close Peter J , Ma’en Al-Mrayat

Paraganglioneuromas producing predominantly dopamine are very rare. Such tumours are potentially malignant and often tend to have atypical clinical presentation. Majority of the patients are normotensive and tumours are detected incidentally on imaging studies. We report a case of dopamine secreting – malignant paraganglioneuroma with spinal metastasis. A 65-year-old man was referred to the endocrinology clinic after an incidental finding of large right para-adrenal mass ...

ea0012p75 | Pituitary | SFE2006

Suprasellar arachnoid cyst: a surgically reversible cause of hypothalamo-pituitary dysfunction

Mallina Ravi K , Simon Godwin , Close Peter J , Al-Mrayat Ma’en

Endocrine manifestations of arachnoid cysts, including suprasellar arachnoid cysts(SAC) are not well recognized. The effect of neurosurgical interventions on such manifestations is also not well reported. Here in we report a case of a young man with hypothalamic dysfunction secondary to SAC who made a good recovery after surgical treatment of the cyst.A 22-yr-old man was referred to our endocrine clinic for evaluation of progressive weight loss and malai...

ea0056p650 | Endocrine tumours and neoplasia | ECE2018

Non-genomic effects of thyroid hormones on mesenchymal stem cells in tumour angiogenesis

Schmohl Kathrin A , Dohmann Maike , Schwenk Nathalie , Bartenstein Peter , Nelson Peter J , Spitzweg Christine

Tumour stroma formation is associated with angiogenesis and requires interactions of various different cell types, including endothelial cells and mesenchymal stem cells (MSCs), which are actively recruited into growing tumour stroma. Thyroid hormones T3 and T4 act as non-classical proangiogenic modulators mediated by non-genomic mechanisms via cell surface receptor integrin αvβ3. The deaminated T4 derivative tetrac is a specific inhibitor of thyroid hormone action a...